The preclinical studies with ISIS 104838 showed it to be effective for the treatment of collagen induced arthritis with activity comparable to that by anti-TNFα antibody [140], and that it successfully knocks down TNFα expression by 85% in stimulated keratinocytes [48]. This evidence concerns the gene TNF and Arthritis.